Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PAT-SM6 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
PAT-SM6 is a monoclonal antibody directed against GRP78, which may result in increased apoptosis and decreased growth of GRP78-expressing tumor cells, especially in combination with other agents (PMID: 23667612, PMID: 27029491, PMID: 31766302). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C103857 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bortezomib + Lenalidomide + PAT-SM6 | Bortezomib Lenalidomide PAT-SM6 | 0 | 0 |
| Dexamethasone + Lenalidomide + PAT-SM6 | Dexamethasone Lenalidomide PAT-SM6 | 0 | 0 |
| Dexamethasone + PAT-SM6 | Dexamethasone PAT-SM6 | 0 | 0 |
| Lenalidomide + PAT-SM6 | Lenalidomide PAT-SM6 | 0 | 0 |
| PAT-SM6 | PAT-SM6 | 0 | 0 |